| Serum cytokeratin-18 is a non-invasive biomarker for evaluating disease severity in patients with liver cirrhosis and hepatocellular carcinoma | |
| Yang, Huayu; Sun, Lejia; Sheng, Langqing; Wang, Xiaowei; Xu, Haifeng; Du, Shunda; Zhao, Haitao; Lu, Xin; Sang, Xinting; Mao, Yilei | |
| 2017 | |
| 卷号 | 6期号:6页码:1345-1350 |
| 关键词 | Cytokeratin-18 (CK18) cytokeratin-18 fragments hepatocellular carcinoma (HCC) cirrhosis biomarker |
| ISSN号 | 2218-676X |
| DOI | 10.21037/tcr.2017.12.12 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6373158 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Yang, Huayu,Sun, Lejia,Sheng, Langqing,et al. Serum cytokeratin-18 is a non-invasive biomarker for evaluating disease severity in patients with liver cirrhosis and hepatocellular carcinoma[J],2017,6(6):1345-1350. |
| APA | Yang, Huayu.,Sun, Lejia.,Sheng, Langqing.,Wang, Xiaowei.,Xu, Haifeng.,...&Mao, Yilei.(2017).Serum cytokeratin-18 is a non-invasive biomarker for evaluating disease severity in patients with liver cirrhosis and hepatocellular carcinoma.,6(6),1345-1350. |
| MLA | Yang, Huayu,et al."Serum cytokeratin-18 is a non-invasive biomarker for evaluating disease severity in patients with liver cirrhosis and hepatocellular carcinoma".6.6(2017):1345-1350. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论